Navigation Links
PNAS announces 2007 Cozzarelli Prize recipients
Date:2/13/2008

WASHINGTON The editors of the Proceedings of the National Academy of Sciences (PNAS) have selected six outstanding PNAS papers for the 2007 Cozzarelli Prize, an award for papers that reflect the highest standards of scientific excellence and originality.

The award was established in 2005 as the PNAS Paper of the Year Prize and renamed the Cozzarelli Prize in 2007 to honor late PNAS Editor-in-Chief Nicholas R. Cozzarelli. The annual award acknowledges papers published in PNAS during the previous year that reflect exceptional contributions to the scientific disciplines represented by the National Academy of Sciences. The 2007 awards will be presented at the PNAS Editorial Board Meeting on April 27, 2008, in Washington, DC.

Papers receiving the Cozzarelli Prize were chosen from more than 3,600 research articles published by PNAS in 2007 and represent the six broadly defined classes under which the National Academy of Sciences is organized.

2007 Cozzarelli Prize Recipients

Class I (Physical and Mathematical Sciences)

Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
by Tommy Cedervall, Iseult Lynch, Stina Lindman, Tord Berggard, Eva Thulin, Hanna Nilsson, Kenneth A. Dawson, and Sara Linse
http://www.pnas.org/cgi/doi/10.1073/pnas.0608582104

A commentary accompanying this article is available:
http://www.pnas.org/cgi/content/extract/104/7/2029

Class II (Biological Sciences)

Muller cells are living optical fibers in the vertebrate retina
by Kristian Franze, Jens Grosche, Serguei N. Skatchkov, Stefan Schinkinger, Christian Foja, Detlev Schild, Ortrud Uckermann, Kort Travis, Andreas Reichenbach, and Jochen Guck
http://www.pnas.org/cgi/content/full/104/20/8287

Class III (Engineering and Applied Sciences)

Faceting ionic shells into icosahedra via electrostatics
by Graziano Vernizzi and Monica Olvera de la Cruz
http://www.pnas.org/cgi/content/full/104/47/18382

Class IV (Biomedical Sciences)

Targeted Delivery of Proteins across the Blood-Brain Barrier
by Brian J. Spencer and Inder M. Verma
http://www.pnas.org/cgi/doi/10.1073/pnas.0702170104

A commentary accompanying this article is available:
http://www.pnas.org/cgi/content/full/104/18/7315

Class V (Behavioral and Social Sciences)

Savanna chimpanzees use tools to harvest the underground storage organs of plants
by R. Adriana Hernandez-Aguilar, Jim Moore, and Travis Rayne Pickering
http://www.pnas.org/cgi/content/full/104/49/19210

A commentary accompanying this article is available:
http://www.pnas.org/cgi/content/full/104/49/19167</p>

Class VI (Applied Biological, Agricultural, and Environmental Sciences)

Incorporating plant functional diversity effects in ecosystem service assessments
by Sandra Diaz, Sandra Lavorel, Francesco de Bello, Fabien Quetier, Karl Grigulis, and T. Matthew Robson
http://www.pnas.org/cgi/content/full/104/52/20684

This article was cited in the PNAS Land Change Science Special Feature:
http://www.pnas.org/cgi/content/full/104/52/20666


'/>"/>

Contact: Jonathan Lifland
pnasnews@nas.edu
202-334-1310
Proceedings of the National Academy of Sciences (PNAS)
Source:Eurekalert

Related medicine news :

1. Microsoft Announces the Amalga Family of Health Enterprise Systems
2. Elsevier Foundation announces grants for innovative libraries and new scholars
3. Elsevier Foundation Announces Grants for Innovative Libraries and New Scholars
4. Echo Therapeutics Announces Closing of Approximately $2.3 Million Private Financing
5. Transition Therapeutics Announces Second Quarter Fiscal 2008 Financial Results
6. XTENT Announces 2007 Financial Results Conference Call
7. Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Proposed Dividend
8. USHEALTH Group Announces Appointment of Executive Vice President
9. Perrigo Company Announces Final FDA Approval for OTC Famotidine Complete Chewable Tablets
10. Herley Industries Announces the Passing of Its Former President
11. GPhA Announces 2008-2009 Executive Committee; Teva North Americas Bill Marth Elected as Chairman of the Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... ... agile ecosystem and domain expertise for sponsors and CROs to speed clinical ... supply management (RTSM) software platform. Bioclinica AGILE RTSM provides seamless ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and funding ... randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients ... complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... 2017  Cardinal Health (NYSE: CAH ) ... earnings per share (EPS) guidance and providing a preliminary ... conjunction with this morning,s announcement of the planned acquisition ... Insufficiency businesses. Cardinal Health now believes that ... at the bottom of its previous guidance range of ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., developer ... series to be presented at the 2017 National Kidney ... today and continues through April 22. Physicians will present ... used to assess risk for acute kidney injury (AKI) ... failure (ADHF). Elevated levels of TIMP-2 ...
Breaking Medicine Technology: